Cost Implications of Oral Contrast Administration in the Emergency Department: A Time-Driven Activity-Based Costing Analysis.


Journal

Journal of the American College of Radiology : JACR
ISSN: 1558-349X
Titre abrégé: J Am Coll Radiol
Pays: United States
ID NLM: 101190326

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 20 06 2018
revised: 25 06 2018
accepted: 20 07 2018
pubmed: 31 8 2018
medline: 1 8 2019
entrez: 31 8 2018
Statut: ppublish

Résumé

To quantify the monetary and time costs associated with oral contrast administration in the emergency department (ED) for patients with nontraumatic abdominal pain and to evaluate the cost savings associated with an institutional policy change in the criteria for oral contrast administration. A HIPAA-complaint, institutional review board-approved time-driven activity-based costing analysis was performed using both prospective time studies and retrospective data obtained from a quaternary care center. Retrospective data spanned a 1-year period (January 1, 2016, to December 31, 2016). A process map was generated. Examination volume-related data, labor costs, and material costs were determined and applied to a base-case model. Univariate and multivariate sensitivity analyses were conducted. Multivariate analysis was used to estimate the cost savings associated with a policy change eliminating oral contrast for patients with body mass index ≥ 25 kg/m The baseline oral contrast utilization rate was 86% (4,541 of 5,263). The annual base-case cost estimate for oral contrast administration was $82,552. In multivariate analyses, this ranged from $13,685 to $315,393. The model was most sensitive to the volume of CTs requiring oral contrast. Applying parameters from the new policy change reduced the annual cost by 52% (cost saving: $35,836.57). Impact of oral contrast on time to discharge was highly variable and dependent on the contrast agent utilized. Costs associated with oral contrast in the ED are modest and should be balanced with its potential diagnostic benefits. Our criteria reduced oral contrast utilization by 52%.

Identifiants

pubmed: 30158081
pii: S1546-1440(18)30893-7
doi: 10.1016/j.jacr.2018.07.021
pii:
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article

Langues

eng

Pagination

30-38

Informations de copyright

Copyright © 2018 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Auteurs

Prasad R Shankar (PR)

Department of Radiology, Michigan Medicine, Ann Arbor, Michigan; Michigan Radiology Quality Collaborative, Michigan Medicine, Ann Arbor, Michigan. Electronic address: pshankar@med.umich.edu.

Kushal R Parikh (KR)

Department of Radiology, Michigan Medicine, Ann Arbor, Michigan; Michigan Radiology Quality Collaborative, Michigan Medicine, Ann Arbor, Michigan.

Marta E Heilbrun (ME)

Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia.

Benjamin M Sweeney (BM)

Department of Industrial and Operations Engineering, University of Michigan, Ann Arbor, Michigan.

Alexis N Flake (AN)

Department of Industrial and Operations Engineering, University of Michigan, Ann Arbor, Michigan.

Emily A Herbstman (EA)

Department of Industrial and Operations Engineering, University of Michigan, Ann Arbor, Michigan.

Trevor J Hoffman (TJ)

Department of Industrial and Operations Engineering, University of Michigan, Ann Arbor, Michigan.

Renee Havey (R)

Department of Emergency Medicine, Michigan Medicine, Ann Arbor, Michigan.

Steven Kronick (S)

Department of Emergency Medicine, Michigan Medicine, Ann Arbor, Michigan.

Matthew S Davenport (MS)

Department of Radiology, Michigan Medicine, Ann Arbor, Michigan; Michigan Radiology Quality Collaborative, Michigan Medicine, Ann Arbor, Michigan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH